6Mallick M, Odedra D, Vidyarthi AS, et al. Meropenem: a potent drug against superbug as unveiled through bioinformatics approaches [J]. Int J Bioinform Res Appl, 2013,9(2) :109 -20.
7Binder L, Schwtorer H, Hoppe S, et al. Pharmacokinetics of mero- penem in critically ill patients with severe infections[J]. Ther Drug Monit, 2013,35( 1 ):63 -70.
8Nakamura A, Miyake K, Misawa S, et al. Meropenem as predictive risk factor for isolation of muhidrug-resistant Pseudomonas aerugino- sa. [J]. JHospInfect, 2013,83(2),153-5.
9Boyer AF, Kollef MH. Probiotics for ventilator-associated pneumo- nia: the need for a large, multicenter, randomized controlled thai. [J]. Chest,2013, 143(3) :590 -2.
